What is DSIP – Delta Sleep‑Inducing Peptide (5MG)?

DSIP – Delta Sleep‑Inducing Peptide – is a naturally occurring nonapeptide (9 amino acids) originally isolated from the cerebral venous blood of rabbits in the 1970s. Its sequence is broadly given as: Trp–Ala–Gly–Gly–Asp–Ala–Ser–Gly–Glu. DSIP has been researched for its possible role in promoting slow-wave (delta) sleep, modulating stress response, growth hormone release, and other neuro-endocrine functions. However, the full physiological role of DSIP remains unresolved, including the natural precursor, receptor(s), and precise mechanisms.

Chemical Structure of DSIP – Delta Sleep‑Inducing Peptide (5MG)

Amino-acid sequence (common representation): Trp–Ala–Gly–Gly–Asp–Ala–Ser–Gly–Glu

Molecular formula: approximately C₃₅H₄₈N₁₀O₁₅

Molecular weight: ~848.8 Da (varies slightly by source)

Discovery note: It is often described as a cyclic or linear nonapeptide depending on variant, but the canonical structure used in studies is linear.

Stability / half-life: The peptide has a very short plasma half-life in humans (often reported ~7-15 minutes) and is rapidly degraded by peptidases unless bound or modified.

What Are the Effects of DSIP – Delta Sleep‑Inducing Peptide (5MG)?

Sleep modulation & growth hormone linkage

In animal models, DSIP administration was associated with increased slow-wave sleep (SWS) and increased growth hormone release following sleep deprivation.

In a human study, DSIP reduced sleep latency and improved sleep efficiency in chronic insomniac patients vs placebo, although the statistical significance was weak and the effect modest.

The original hypothesis that DSIP is a “sleep-promoting factor” remains only partially supported: some studies show effect, others fail to replicate strong sleep-inducing benefits.

Neuroendocrine & stress-response roles

DSIP has been shown to impact the hypothalamic-pituitary axis and stress hormone regulation (e.g., ACTH, cortisol) in animal models.

It exhibits neuroprotective properties: in rat stroke models, DSIP treated animals recovered motor function faster and showed reduced oxidative injury in brain tissue.

Other research observations

Potential analgesic and anticonvulsant effects in animal studies.

Some evidence suggests DSIP may influence body-temperature regulation, blood pressure, and metabolism, though these are less well characterised.

Summary of your found content

The content you found is largely correct:

Sequence and origin of DSIP are accurate.

Effects you described (sleep modulation, neuro-endocrine modulation) align with established research.
What needed improvement:

Emphasis on uncertainty and limited replication of sleep-promoting claims.

Specification of molecular weight / formula should include “approximate” and highlight variation among sources.

Clarification that many effects are from animal/in vitro models and that human data is limited.

Use-Wise Notes

This peptide is for research use only. It is not approved for therapeutic or dietary use.

Quality and storage: It should be supplied as high-purity lyophilised powder, stored at ≤ −20°C (or per supplier instructions), protected from moisture/light.

When listing product details, it is advisable to include: sequence, molecular weight/approx range, intended research applications, purity specification, storage instructions, and legal disclaimer.

IRON2510230089